Release date: 2008-01-02 Long-term oral administration of hormones helps reduce the risk of lymphoma in patients with rheumatoid arthritis Dr. Eva Baecklund of Uppsala University in Switzerland recently pointed out that oral hormonal therapy for patients with rheumatoid arthritis for more than 2 years can reduce the risk of lymphoma, the patient's This benefit is not related to when hormone therapy begins in the course of the disease, but the course of treatment must be more than 2 years. A total of 756 patients with rheumatoid arthritis were enrolled in the study, with 378 patients with/without RA-associated lymphoma. After comparing the types of oral hormones, the course of treatment, the pathological type of lymphoma, and the course of RA during hormone therapy, the researchers found that the duration of RA and the time to start hormone therapy were not related to whether the patient had lymphoma. The risk of lymphoma in patients treated with hormone therapy for 2 years or more can be significantly reduced (relative risk: 0.4, 0.2 to 0.7), and oral hormones are most effective in preventing large B-cell lymphoma (relative risk: 0.7, 0.4 to 1.0) ). ——Midi Medical Network Dried Red Goji Berries,Organic Dried Red Goji Berries,Dried Sweet Red Goji Berry,Dried Red Goji Fruit Berry Ningxia ZhaiXianSong Commercial and Trading Co.,Ltd. , https://www.nxupin.com